We are live on
!
Find out more
HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
+2.53%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.95B
AUM Growth
-$46.9M
(-2.3%)
Cap. Flow
-$62.6M
Cap. Flow
% of AUM
-3.21%
Top 10 Holdings %
Top 10 Hldgs %
49.13%
Holding
66
New
15
Increased
17
Reduced
12
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$61.3M |
| 2 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$59.5M |
| 3 |
Universal Health Services
UHS
|
+$53.1M |
| 4 |
AGN
Allergan Inc
AGN
|
+$41.6M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$39.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$78.3M |
| 2 |
CFN
CAREFUSION CORPORATION
CFN
|
+$71M |
| 3 |
eHealth
EHTH
|
+$61.7M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$53.4M |
| 5 |
MDVN
MEDIVATION, INC.
MDVN
|
+$46.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 64.19% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNK
1
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $162M | 8.33% |
1,800,000
+500,000
| +38% | +$39.1M |
|
|
SLXP
2
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $146M | 7.5% |
935,100
+410,100
| +78% | +$59.5M |
|
3
Intuitive Surgical
ISRG
$126B
| $99.3M | 5.1% |
1,935,000
+745,200
| +63% | +$37M |
|
|
MDRX
4
DELISTED
Veradigm Inc. Common Stock
MDRX
| $96.7M | 4.97% |
7,210,000
-1,990,000
| -22% | -$30.2M |
|
|
WMGI
5
DELISTED
Wright Medical Group Inc
WMGI
| $95.4M | 4.9% |
3,150,000
| – | – |
|
6
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $78.8M | 4.05% |
+400,000
| New | +$79.1M |
|
|
CBST
7
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $73M | 3.75% |
1,100,000
-125,000
| -10% | -$8.21M |
|
8
Viatris
VTRS
$20.7B
| $70.5M | 3.62% |
1,550,000
+375,000
| +32% | +$18.2M |
|
9
Danaher
DHR
$138B
| $68.4M | 3.51% |
1,339,049
+363,924
| +37% | +$18.7M |
|
|
10
Biogen
BIIB
$30.7B
| $66.2M | 3.4% |
200,000
+186,000
| +1,329% | +$61.3M |
|
11
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
| $63.9M | 3.28% |
+1,000,000
| New | +$62.6M |
|
|
CTRX
12
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $63.2M | 3.25% |
1,500,000
+366,500
| +32% | +$16.7M |
|
13
Agilent Technologies
A
$39.2B
| $59.8M | 3.07% |
1,467,900
-908,700
| -38% | -$37.1M |
|
|
WBMD
14
DELISTED
WebMD Health Corp.
WBMD
| $53.6M | 2.75% |
1,281,200
+306,200
| +31% | +$14.8M |
|
15
McKesson
MCK
$101B
| $53.5M | 2.75% |
275,000
-7,100
| -3% | -$1.37M |
|
|
16
Universal Health Services
UHS
$9.88B
| $52.3M | 2.68% |
+500,000
| New | +$53.1M |
|
|
MDVN
17
DELISTED
MEDIVATION, INC.
MDVN
| $51.9M | 2.67% |
1,050,000
-1,100,000
| -51% | -$46.7M |
|
|
AGN
18
CALL
DELISTED
Allergan plc
AGN
| $48.3M | 2.48% |
+200,000
| New | +$44.8M |
|
|
AGN
19
DELISTED
Allergan Inc
AGN
| $44.6M | 2.29% |
+250,300
| New | +$41.6M |
|
20
HCA Healthcare
HCA
$85.7B
| $44.1M | 2.26% |
625,000
-239,900
| -28% | -$15.9M |
|
|
HZNP
21
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $43.9M | 2.25% |
3,575,000
+875,000
| +32% | +$10.2M |
|
|
NUVA
22
DELISTED
NuVasive, Inc.
NUVA
| $41.8M | 2.15% |
1,200,000
-250,000
| -17% | -$8.9M |
|
23
CALL
Vertex Pharmaceuticals
VRTX
$122B
| $39.3M | 2.02% |
350,000
-217,000
| -38% | -$20.7M |
|
|
AGN
24
DELISTED
Allergan plc
AGN
| $36.2M | 1.86% |
150,000
-350,000
| -70% | -$78.3M |
|
|
TSRO
25
DELISTED
TESARO, Inc.
TSRO
| $32.3M | 1.66% |
1,198,795
-276,205
| -19% | -$8.12M |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q3 2014 Portfolio in Review
As of Q3 2014, HealthCor Management held 66 positions worth $1.95B, down 2.3% from $1.99B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
HealthCor Management withdrew a net $62.6M in Q3 2014, closing 17 positions and reducing 12 holdings. Its most notable exit was CAREFUSION CORPORATION, an estimated $71M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, down from 73% a quarter earlier, followed by Financials.
Against the trend, HealthCor Management opened a new position in Universal Health Services worth $52.3M.
- HealthCor Management's largest Q3 2014 buy was Universal Health Services: 500,000 shares worth $52.3M.
- HealthCor Management added most to Biogen in Q3 2014, an estimated $61.3M increase.
- HealthCor Management's biggest Q3 2014 reduction was Allergan plc, cutting an estimated $78.3M.
- HealthCor Management fully exited CAREFUSION CORPORATION in Q3 2014, selling an estimated $71M.
- HealthCor Management's ten largest holdings make up 49% of its $1.95B portfolio in Q3 2014.
- HealthCor Management opened 15 new positions and closed 17 in Q3 2014.
- HealthCor Management's portfolio value fell 2.3% quarter-over-quarter to $1.95B.
Based on HealthCor Management's 13F filing for Q3 2014, filed 14 Nov 2014.